Back
Genesco, Inc. 10K Form
Sell
44
GCO
Genesco, Inc.
Last Price:
$22.16
Seasonality Move:
10.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-13 | 10Q | GCO/Genesco, Inc. Quarterly |
| 2023-12-07 | 10Q | GCO/Genesco, Inc. Quarterly |
| 2023-09-07 | 10Q | GCO/Genesco, Inc. Quarterly |
| 2023-06-08 | 10Q | GCO/Genesco, Inc. Quarterly |
| 2022-12-08 | 10Q | GCO/Genesco, Inc. Quarterly |
| 2022-09-08 | 10Q | GCO/Genesco, Inc. Quarterly |
Receive GCO News And Ratings
See the #1 stock for the next 7 days that we like better than GCO
GCO Financial Statistics
Sales & Book Value
| Annual Sales: | $2.3B |
|---|---|
| Cash Flow: | $-31.5M |
| Price / Cash Flow: | 10.2 |
| Annual Sales: | $47.53 |
| Price / Book: | 0.47 |
Profitability
| EPS (TTM): | -0.18420 |
|---|---|
| Net Income (TTM): | $-693K |
| Gross Margin: | $1.1B |
| Return on Equity: | -0.13% |
| Return on Assets: | -0.05% |
Genesco, Inc. Earnings Forecast
Key Genesco, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for GCO is 47.17%.
-
The Selling, General & Administrative Expenses for GCO have been equal to 46.44% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of GCO is -0.84% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 20 years.
Genesco, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Specialty Retail |
| Sector: | Consumer Discretionary |
| Current Symbol: | GCO |
| CUSIP: | 371532 |
| Website: | genesco.com |
Debt
| Debt-to-Equity Ratio: | 1.19 |
|---|---|
| Current Ratio: | 1.58 |
| Quick Ratio: | 0.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 11.96 |
GCO Technical Analysis vs Fundamental Analysis
Sell
44
Genesco, Inc. (GCO)
is a Sell
Is Genesco, Inc. a Buy or a Sell?
-
Genesco, Inc. stock is rated a SellThe current Genesco, Inc. [GCO] share price is $22.56. The Score for GCO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.